NIH-funded research NIH-funded research

Understanding how cells take in nutrients and signals

Official title: Molecular mechanisms of endocytic initiation and cargo selection

Funded at Univ of North Carolina Chapel Hill · NIH-10932175 · Data updated 2026-11-12

This study is looking at how cells take in important nutrients and signals from their surroundings, focusing on a special protein complex called AP2 that helps decide what gets brought inside the cell, which could help us understand how cells work and respond to their environment better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 20, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$388,750
NIH project number5R35GM150960-02
Project IDNIH-10932175 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions that involve disrupted cellular signaling or nutrient uptake, such as specific types of cancer.

Less likely to help

Patients with conditions unrelated to cellular endocytosis or those not affected by signaling pathways may not benefit from this research.

What this research studies

This research investigates the early stages of clathrin-mediated endocytosis, a crucial process by which cells internalize nutrients and signals from their environment. The focus is on the AP2 clathrin adaptor complex, which plays a key role in selecting what gets internalized. By examining how AP2 interacts with various proteins and responds to regulatory signals, the research aims to uncover the mechanisms that control cargo selection during endocytosis. This understanding could provide insights into how cells maintain their functions and respond to external cues.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for targeting diseases related to cellular signaling and nutrient uptake, including certain cancers.

How similar studies have gone: While the mechanisms of later stages of endocytosis have been well-studied, this research explores relatively uncharted territory, making it a novel approach.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Baker, Richard Wayne — Univ of North Carolina Chapel Hill
  • Study coordinator: Baker, Richard Wayne

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.